1

Probiodrug, Germany

Drug development Alzheimer

www.probiodrug.de

HBM contact: Dr Ivo Staijen

Company status: public

Probiodrug focuses on the discovery and development of new Alzheimer’s drugs.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171